Cardiometabolic Disorders News

The proportion of adults with diabetes and obesity in the U.S. increased from 1999 to 2020, though more adults achieved blood pressure and lipid control during that period, according to a study published in Obesity.

About one-third of adults who were prescribed a GLP-1 receptor agonist to treat type 2 diabetes lost at least 5% of their body weight at 72 weeks, according to findings from a real-world retrospective analysis.

A brief alcohol-related intervention in people with unhealthy alcohol use was linked to reduction of diastolic BP in patients with hypertension but did not improve outcomes in patients with type 2 diabetes, researchers reported.

Findings from a meta-regression analysis indicated that the beneficial effects of SGLT2 inhibition on CV death and HF hospitalization in patients with diabetes may be related to body weight.

Data from a large U.S. survey show a noninvasive visceral adiposity index score, a metric for assessing obesity, can independently predict and serve as a novel marker of HF risk, researchers reported.

Vitamin B status was inversely associated with incident metabolic syndrome among Black and white young adults in the U.S., according to an analysis of the CARDIA study published in JAMA Network Open.

There is not yet enough evidence to adequately assess the benefit-harm balance of screening for lipid disorders in asymptomatic children and adolescents aged 20 years or younger, according to a statement from the U.S. Preventive Services Task Force.

An 8-hour time-restricted eating intervention did not improve insulin sensitivity, insulin secretion or beta-cell function in a small group of adults with overweight or obesity, according to data from a randomized controlled trial.

Among adults with overweight or obesity, weight loss of 10%, with or without physical activity, improved biomarkers of insulin resistance and cardiometabolic health, according to results of a secondary analysis of the Heart Health Study.

Adults with type 2 diabetes may be able to reduce their liver fat and improve their liver fibrosis stage with reductions in HbA1c, according to a study published in Nutrition, Metabolism & Cardiovascular Diseases.